Lubricant of Motion: Synovial Fluid-Derived Mesenchymal Stromal/Stem Cells for Cartilage and Joint Regeneration

Abstract

Synovial fluid has historically been regarded as a specialized biological lubricant responsible for reducing friction, distributing mechanical loads, and supporting cartilage nutrition within diarthrodial joints. Recent advances in regenerative medicine have revealed that synovial fluid also contains mesenchymal stromal/stem cell (MSC)-like populations with significant regenerative and immunomodulatory properties. These synovial fluid-derived mesenchymal stromal/stem cells (SF-MSCs) are believed to originate predominantly from the synovial membrane and other joint-associated progenitor niches, exhibiting robust clonogenicity, multilineage differentiation, and superior chondrogenic potential. Emerging evidence suggests that SF-MSCs contribute to joint homeostasis through cartilage matrix production, immunomodulation, and paracrine signaling mediated by extracellular vesicles and exosomes. Consequently, SF-MSCs have attracted considerable interest as a candidate cell source for cartilage repair, meniscal regeneration, osteochondral reconstruction, disease modeling, and cell-free regenerative therapies. Although encouraging preclinical and early clinical studies support their therapeutic promise, significant challenges remain regarding cellular heterogeneity, standardization, manufacturing, and long-term efficacy. This commentary reviews the biological characteristics, mechanisms of action, translational applications, current limitations, and future perspectives of SF-MSCs in orthopedic regenerative medicine.